We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended eight new drugs for approval at its April meeting, including copycat versions of Novo Nordisk’s NovoLog insulin and Novartis’ multiple sclerosis drug Gilenya. Read More
Moderna has signed a 10-year agreement with Swiss manufacturer Lonza to manufacture its COVID-19 vaccine candidate and other future products. Read More
The FDA on Friday granted Gilead’s remdesivir an Emergency Use Authorization (EUA) as a COVID-19 treatment, based on positive results from two clinical trials. Read More
Gilead announced that it has 1.5 million individual doses of its antiviral remdesivir available for use as a COVID-19 treatment and will donate the doses when they’re needed. Read More